FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Painter Tyler 		2. Issuer Name and Ticker or Trading Symbol

SOLAZYME INC [ SZYM ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
CFO and COO
(Last)          (First)          (Middle)

SOLAZYME, INC., 225 GATEWAY BOULEVARD 		3. Date of Earliest Transaction (MM/DD/YYYY)

2/19/2015
(Street)

SOUTH SAN FRANCISCO, CA 94080
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock                  401062   (1) D  
 

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (right to buy)   $8.77   2/19/2015     D         50000      (2) 3/8/2021   Common Stock   50000     (3) 0   D  
 
Employee Stock Option (right to buy)   $2.50   2/19/2015     A      25000         (4) 3/8/2021   Common Stock   25000     (3) 25000   D  
 
Employee Stock Option (right to buy)   $11.49   2/19/2015     D         100000      (5) 2/10/2022   Common Stock   100000     (6) 0   D  
 
Employee Stock Option (right to buy)   $2.50   2/19/2015     A      50000         (4) 2/10/2022   Common Stock   50000     (6) 50000   D  
 
Employee Stock Option (right to buy)   $8.35   2/19/2015     D         50000      (7) 2/24/2023   Common Stock   50000     (8) 0   D  
 
Employee Stock Option (right to buy)   $2.50   2/19/2015     A      25001         (9) 2/24/2023   Common Stock   25001     (8) 25001   D  
 
Employee Stock Option (right to buy)   $11.11   2/19/2015     D         60000      (10) 2/11/2024   Common Stock   60000     (11) 0   D  
 
Employee Stock Option (right to buy)   $2.50   2/19/2015     A      30000         (12) 2/11/2024   Common Stock   30000     (11) 30000   D  
 
Employee Stock Option (right to buy)   $9.52   2/19/2015     D         200000      (13) 5/21/2024   Common Stock   200000     (14) 0   D  
 
Employee Stock Option (right to buy)   $2.50   2/19/2015     A      100000         (15) 5/21/2024   Common Stock   100000     (14) 100000   D  
 

Explanation of Responses:
( 1)  Includes 2,500 shares acquired under the Solazyme Employee Stock Purchase Plan.
( 2)  The option provided for monthly vesting as to 1/48 of the underlying shares beginning on March 9, 2011.
( 3)  On February 19, 2015, the issuer canceled, pursuant to the issuer's option exchange program, an option for 50,000 shares of SZYM common stock granted to the reporting person on March 9, 2011. In exchange, the reporting person received a replacement option, for 25,000 shares, having an excercise price of $2.58 a share.
( 4)  The option vests in full on January 1, 2016.
( 5)  The option provided for monthly vesting as to 1/48 of the underlying shares beginning on January 1, 2012.
( 6)  On February 19, 2015, the issuer canceled, pursuant to the issuer's option exchange program, an option for 100,000 shares of SZYM common stock granted to the reporting person on February 11, 2012. In exchange, the reporting person received a replacement option, for 50,000 shares, having an excercise price of $2.58 a share.
( 7)  The option provided for monthly vesting as to 1/48 of the underlying shares beginning on January 1, 2013.
( 8)  On February 19, 2015, the issuer canceled, pursuant to the issuer's option exchange program, an option for 50,000 shares of SZYM common stock granted to the reporting person on February 25, 2013. In exchange, the reporting person received a replacement option, for 25,001 shares, having an excercise price of $2.58 a share.
( 9)  The option vests as to 18,750 shares on January 1, 2016 and as to 1/48 of the underlying shares monthly thereafter.
( 10)  The option provided for monthly vesting as to 1/48 of the underlying shares beginning on January 1, 2014.
( 11)  On February 19, 2015, the issuer canceled, pursuant to the issuer's option exchange program, an option for 60,000 shares of SZYM common stock granted to the reporting person on February 12, 2014. In exchange, the reporting person received a replacement option, for 30,000 shares, having an excercise price of $2.58 a share.
( 12)  The option vests as to 15,000 shares on January 1, 2016 and as to 1/48 of the underlying shares monthly thereafter.
( 13)  The option provided for monthly vesting as to 1/48 of the underlying shares beginning on May 22, 2014.
( 14)  On February 19, 2015, the issuer canceled, pursuant to the issuer's option exchange program, an option for 200,000 shares of SZYM common stock granted to the reporting person on May 22, 2014. In exchange, the reporting person received a replacement option, for 100,000 shares, having an excercise price of $2.58 a share.
( 15)  The option vests as to 39,583 shares on January 1, 2016 and as to 1/48 of the underlying shares monthly beginning December 22, 2015.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Painter Tyler
SOLAZYME, INC.
225 GATEWAY BOULEVARD
SOUTH SAN FRANCISCO, CA 94080

CFO and COO

Signatures
/s/ Paul Quinlan, as attorney-in-fact 2/20/2015
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.